Carmen Calles

Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment

The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects

Relapsing–Remitting Multiple Sclerosis Is Characterized by a T Follicular Cell Pro-Inflammatory Shift, Reverted by Dimethyl Fumarate Treatment

Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers